Celgene Corporation improvements on Phase II research evaluating apremilast in psoriatic arthritis patients Celgene Company announced that updated results of a phase II, multi-middle, randomized, double-blind, placebo-controlled, three-arm study of apremilast in adult individuals with psoriatic arthritis were presented today in the American College of Rheumatology 2009 annual conference in Philadelphia, PA. CC-10004-PSA-001 sought to determine the efficacy and safety of apremilast in 204 sufferers at two different dosing regimens – 20mg two times per time or 40mg once per day in comparison to placebo after 12 weeks, with 126 sufferers participating in an expansion of the study for yet another 12 weeks is propranolol an otc drug http://propranolol-hcl.net/generic-propranolol-online .
About Creative Diagnostics Creative Diagnostics is a respected supplier and manufacturer of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. The business provides agreement biologic R&D and making providers and biological testing services to the diagnostic manufacturers along with GMP biologics making for the biopharmaceutical market. Its goal is to supply a trusted source for all kinds of assay manufacturing and development needs.. Cell Counting Products Used to Determine Cell Viability Cell counting package is a straightforward, reliable, sensitive, reproducible, inexpensive and high-throughput method to determine the cell viability in cell proliferation and cytotoxicity.